e-Therapeutics plc (LON:ETX) shares passed below its 200-day moving average during trading on Thursday . The stock has a 200-day moving average of $2.83 and traded as low as $2.53. e-Therapeutics shares last traded at $2.53, with a volume of 198,216 shares changing hands.
The company has a 50 day simple moving average of GBX 3.28 and a 200-day simple moving average of GBX 2.81. The stock has a market capitalization of $6.86 million and a price-to-earnings ratio of -1.70.
e-Therapeutics Company Profile (LON:ETX)
e-Therapeutics plc engages in the discovery of drugs through its proprietary network-driven drug discovery platform in the United Kingdom. It is developing two NDD-derived immuno-oncology programs, including tryptophan catabolism and immune checkpoint modulation. The company, through its subsidiary, Searchbolt Limited, develops search engine technology.
Featured Story: Call Option Volume
Receive News & Ratings for e-Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for e-Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.